ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,179Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 336

$1.37M Total Retail Price of All Prescriptions

Rank: 11 out of 336

580 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 580 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

64% of this provider’s 580 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

5% of this provider’s 14,071 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 3,001 1,062 S3 1 2
CARISOPRODOL 2,012 293 R 10 2 63
AMLODIPINE BESYLATE 670 404 3 1
LISINOPRIL 647 335 4 6
FUROSEMIDE 644 459 5 4
ZOLPIDEM TARTRATE 552 211 6 18
GABAPENTIN 544 254 7 11
DOXYCYCLINE HYCLATE 471 160 8 92
POTASSIUM CHLORIDE 437 318 9 9
CARVEDILOL 435 316 10 13
SIMVASTATIN 424 249 11 5
LEVOTHYROXINE SODIUM 398 236 12 7
CIPROFLOXACIN HCL 387 185 13 55
WARFARIN SODIUM 370 272 14 17
ATORVASTATIN CALCIUM 344 231 15 14
OMEPRAZOLE 334 162 16 3
GLIMEPIRIDE 310 183 17 29
HYDRALAZINE HCL 284 164 18 53
METOPROLOL SUCCINATE 275 184 19 15
CITALOPRAM HBR 265 173 20 21
METFORMIN HCL 258 84 21 8
METOPROLOL TARTRATE 247 116 22 16
ALENDRONATE SODIUM 241 188 23 54
FAMOTIDINE 224 135 24 73
ENALAPRIL MALEATE 213 116 25 60
ALLOPURINOL 211 133 26 30
RANITIDINE HCL 211 165 26 36
LEVETIRACETAM 207 92 28 114
FENTANYL 200 71 S2 29 120
TRAZODONE HCL 195 114 30 46
PROMETHAZINE HCL 193 94 R 31 99
DONEPEZIL HCL 192 176 32 27
PREDNISONE 191 89 33 48
OXYCODONE HCL-ACETAMINOPHEN 184 69 S2 34 136
FLUTICASONE PROPIONATE 180 54 35 49
NAMENDA 173 159 36 39
HYDROCHLOROTHIAZIDE 162 77 37 12
POLYETHYLENE GLYCOL 3350 162 117 37 68
PANTOPRAZOLE SODIUM 149 112 39 40
LYRICA 149 37 39 70
MELOXICAM 147 81 41 19
LANTUS 136 73 42 56
DIOVAN 134 61 43 31
SERTRALINE HCL 130 99 44 33
CLONIDINE HCL 127 78 45 32
TIZANIDINE HCL 126 71 46 83
OXYCODONE HCL 121 16 S2 47 184
PRAVASTATIN SODIUM 120 71 48 10
SINGULAIR 119 69 49 85
NOVOLIN R 117 70 50 181
BUDESONIDE 117 111 50 320
NEXIUM 115 42 52 24
BACLOFEN 115 38 52 179
PLAVIX 114 93 54 37
TRAMADOL HCL 113 53 55 20
DIOVAN HCT 111 61 56 41
CLOPIDOGREL 108 86 57 28
TAMSULOSIN HCL 108 52 57 38
COMBIVENT 106 39 59 152
ISOSORBIDE MONONITRATE ER 103 67 60 44
SPIRONOLACTONE 103 65 60 42
MEGESTROL ACETATE 100 83 R 62 110
NAPROXEN 97 44 63 80
CYCLOBENZAPRINE HCL 96 44 R 64 65
SULFAMETHOXAZOLE-TRIMETHOPRIM 95 52 65 89
CIMETIDINE 94 44 66 280
VERAPAMIL ER 92 31 67 95
ATENOLOL 91 50 68 26
QUETIAPINE FUMARATE 90 69 69 94
COLCRYS 89 64 70 103
IPRATROPIUM-ALBUTEROL 86 74 71 232
BUSPIRONE HCL 85 79 72 113
FLUCONAZOLE 84 44 73 151
FLUOXETINE HCL 83 33 74 81
AMOXICILLIN 83 42 74 128
MOMETASONE FUROATE 82 43 76 336
IBUPROFEN 82 20 76 118
ENDOCET 79 20 S2 78 141
HYDROXYZINE HCL 79 52 R 78 222
FLOVENT HFA 79 18 78 340
DIGOXIN 79 62 78 50
HYDROMORPHONE HCL 78 36 S2 82 341
MIRTAZAPINE 77 47 83 66
CYMBALTA 77 62 83 52
GLIPIZIDE XL 77 39 83 174
SPIRIVA 75 51 86 88
NOVOLOG 75 53 86 135
HUMULIN N 74 40 88 184
RISPERIDONE 70 66 89 90
LIPITOR 69 30 90 62
AGGRENOX 68 25 91 133
PHENYTOIN SODIUM EXTENDED 68 38 91 97
MECLIZINE HCL 67 41 93 96
DIVALPROEX SODIUM 66 45 94 142
ESCITALOPRAM OXALATE 66 55 94 69
NOVOLIN 70-30 65 39 96 163
MONTELUKAST SODIUM 64 31 97 140
NAPROXEN SODIUM 64 17 97 356
MEGACE ES 63 47 R 99 320
VOLTAREN 61 32 100 234
SANTYL 60 26 101 281
LIDODERM 59 39 102 256
AMIODARONE HCL 57 41 103 117
HUMULIN R 57 23 103 230
ADVAIR DISKUS 56 20 105 82
VENLAFAXINE HCL ER 55 27 106 100
AZITHROMYCIN 55 21 106 58
LOVASTATIN 52 31 108 34
ALBUTEROL SULFATE 52 44 108 228
NYSTATIN 51 37 110 212
METFORMIN HCL ER 50 21 111 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.